ENVB - Enveric Biosciences Inc

https://www.enveric.com

Momentum: Bearish

Recent News

No recent news found.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.

52W High

$8.32

52W Low

$0.91

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.37

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

23.09

EV/EBITDA (<8 favorable)

0.29

EV/Revenue (<3 favorable)

1.76

P/S (TTM) (<3 favorable)

0.08

P/B (<3 favorable)

1.35

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

6.84%

Institutions (25–75% balanced)

10.20%

Shares Outstanding

3,246,300

Float

3,222,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

2008-04-23

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

35,405,100

Gross Profit (TTM)

8,150,700

EPS (TTM)

-9.97

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-2.62%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.07

Momentum

Bearish momentum

Value

-0.0883

-0.0908

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025